MolCell MMDesign achieves breakthrough progress in the AI pharmaceutical field

MolCell AI's MMDesign platform completes 18 design projects with a success rate of 94.7%, hitting all six GPCR targets among them, with the best affinity reaching nanomolar level; the platform uses a 'generate-screen-verify' workflow, generating tens of thousands of candidate molecules in computational space and testing only 9-50 to achieve success, with an overall candidate hit rate of 30.7%, demonstrating efficient and precise molecular design capabilities.